Patient-support services programs have become common in the pharmaceutical industry and are now considered table stakes for certain disease states. Yet recent government scrutiny has left some pharma companies wondering what to do with these programs in the future.
This POV reviews the current state of affairs and lays out recommendations from overall business, compliance, legal, and regulatory viewpoints. Download it to get the details!
Related Posts
09|27|22
The Changing World of Streaming: Three Things Pharma Marketers Need to Know Now
Britt Travis of our Video Investment team explains what’s currently happening with streaming TV, and what pharma advertisers need to do.
06|06|22
Speak to the Heart
Director of Strategic Planning Nicole McCann-Davis shares the throughline of success in her career: whatever your goal, whoever your audience, you have to speak to their heart and inspire feeling.
05|19|22
Five Themes to Consider for Your Strategic Planning
John Kenny, SVP of Strategic Planning, unveils the five key themes that were the focus of 2022’s annual internal brand-planning conference.